KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Historic Asset Writedowns and Impairment for Zimmer Biomet Holdings (ZBH) over the last 7 years, with Q4 2022 value amounting to $289.8 million.

  • Zimmer Biomet Holdings' Asset Writedowns and Impairment changed N/A to $289.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $292.8 million, marking a year-over-year increase of 33293.56%. This contributed to the annual value of $292.8 million for FY2022, which is 169631.9% up from last year.
  • As of Q4 2022, Zimmer Biomet Holdings' Asset Writedowns and Impairment stood at $289.8 million.
  • Zimmer Biomet Holdings' Asset Writedowns and Impairment's 5-year high stood at $975.9 million during Q4 2018, with a 5-year trough of -$142.0 million in Q4 2020.
  • Over the past 5 years, Zimmer Biomet Holdings' median Asset Writedowns and Impairment value was $33.0 million (recorded in 2020), while the average stood at $206.9 million.
  • The largest annual percentage gain for Zimmer Biomet Holdings' Asset Writedowns and Impairment in the last 5 years was 25878.68% (2018), contrasted with its biggest fall of 8837.92% (2018).
  • Over the past 5 years, Zimmer Biomet Holdings' Asset Writedowns and Impairment (Quarter) stood at $975.9 million in 2018, then tumbled by 92.82% to $70.1 million in 2019, then tumbled by 302.57% to -$142.0 million in 2020, then surged by 111.48% to $16.3 million in 2021, then soared by 1677.91% to $289.8 million in 2022.
  • Its Asset Writedowns and Impairment stands at $289.8 million for Q4 2022, versus $3.0 million for Q2 2022 and $16.3 million for Q2 2021.